Verrica Pharmaceuticals Inc. (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

4.820

-0.040 (-0.82%)

At close: Aug 21, 2026, 4:00 PM EDT

4.860

+0.040 (0.83%)

After-hours: Aug 21, 2026, 7:30 PM EDT

Verrica Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	30.32	35.58	7.57	5.12	9.03	12
Revenue Growth	106.21%	370.22%	47.66%	-43.27%	-24.73%	-
Cost of Revenue	18.9	12.3	14.58	21.04	12.92	15.93
Gross Profit	11.43	23.28	-7.01	-15.92	-3.89	-3.93
Selling, General & Admin	37.86	35.22	58.82	47.31	17.41	26.98
Operating Expenses	37.86	35.22	58.82	47.31	17.41	26.98
Operating Income	-26.43	-11.94	-65.84	-63.22	-21.3	-30.91
Interest Expense	-3.73	-7.74	-9.41	-3.96	-2.17	-4.3
Interest & Investment Income	0.68	0.93	1.42	2.74	0.48	0.12
Other Non Operating Income (Expenses)	1.78	2.65	-2.67	-0.01	-0.06	-
EBT Excluding Unusual Items	-27.71	-16.11	-76.5	-64.46	-23.05	-35.08
Gain (Loss) on Sale of Assets	-0.25	-0.25	-0.08	-2.54	-	-
Other Unusual Items	-1.53	-1.53	-	-	-1.44	-
Pretax Income	-31.18	-17.89	-76.58	-67	-24.49	-35.08
Earnings From Continuing Operations	-	-17.89	-76.58	-67	-24.49	-35.08
Net Income	-31.18	-17.89	-76.58	-67	-24.49	-35.08
Net Income to Common	-31.18	-17.89	-76.58	-67	-24.49	-35.08
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	17	11	5	5	3	3
Shares Outstanding (Diluted)	17	11	5	5	3	3
Shares Change	117.95%	105.61%	14.26%	32.72%	26.32%	8.20%
EPS (Basic)	-1.88	-1.68	-14.78	-14.78	-7.17	-12.97
EPS (Diluted)	-1.88	-1.68	-14.78	-14.78	-7.17	-13.00
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-13.35	-17.63	-60.95	-38.94	-18.95	-28.47
Free Cash Flow Per Share	-0.81	-1.66	-11.77	-8.59	-5.55	-10.53
Gross Margin	37.68%	65.44%	-92.70%	-	-43.08%	-32.74%
Operating Margin	-87.18%	-33.56%	-870.16%	-1233.84%	-235.78%	-257.57%
Profit Margin	-102.84%	-50.27%	-1012.15%	-1307.47%	-271.11%	-292.33%
Free Cash Flow Margin	-44.02%	-49.55%	-805.63%	-759.93%	-209.83%	-237.21%
EBITDA	-25.96	-11.45	-64.88	-62.67	-20.84	-30.66
EBITDA Margin	-85.63%	-32.20%	-	-	-230.76%	-255.53%
D&A For EBITDA	0.47	0.49	0.96	0.55	0.45	0.24
EBIT	-26.43	-11.94	-65.84	-63.22	-21.3	-30.91
EBIT Margin	-87.18%	-33.56%	-	-	-235.78%	-257.57%
Revenue as Reported	30.32	35.58	7.57	5.12	9.03	-

SEC Filings: 10-K · 10-Q